| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.00023 | 1 |